AlphAIAlphAI — Financial news for AI agents
tradingview.com$ENSG

UBS maintains Ensign Group at Buy, raises price target to $240 from $230

UBS kept its Buy rating on Ensign Group and increased its price target to $240 from $230, suggesting a 30.4% upside from the Oct 28 close of $184.11, according to the firm.

Original reporting
tradingview.com
Published Oct 29, 2026, 4:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 4:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
UBS maintains Ensign Group at Buy, raises price target to $240 from $230 — source image
Source · tradingview.com
Decision brief

The 30-second read

$ENSGBullishLow
01

Why it matters

UBS's price target increase could attract short-term buying, but the effect may be modest given the company's size.

02

Market read

A modest analyst upgrade that may generate limited trading activity.

03

What to watch

Potential downside from upcoming earnings volatility or macro headwinds not addressed.

Relevance 5/10Novelty 5/10Timing: today

Background

Ensign Group is a small-cap industrial services firm; analyst coverage is limited.

Company-level read

Ticker impact

$ENSGBullishMedium confidence
Context

UBS raised Ensign Group's price target to $240 from $230, indicating a fresh analyst upgrade.

Expected impact

potential upside as investors price in the higher target

Evidence & confidence

The new target suggests UBS expects stronger performance, prompting buying interest.

Market effects

Sector

Minimal impact on the broader sector; only a single stock receives a target lift.

Regional

US market focus; no notable regional effect.

Global

Limited to investors tracking analyst upgrades.

Counterpoint

What could challenge this read

The target raise may be premature if earnings fail to meet expectations.

Key entities

  • Analyst
    UBS

    Investment bank providing the rating upgrade.

  • Company
    Ensign Group

    Subject of the price target change.

Read at source← All news

Related articles

$DHCMedAI 8/10

DHC Q3 2026 slides: SHOP segment surges 50% despite earnings miss

Diversified Healthcare Trust (DHC) reported Q3 2026 results with a net loss of $0.21 per share, missing estimates. Shares fell 2.58% to $7.54. The SHOP segment saw a 50.4% NOI increase, while medical office and life science faced challenges. DHC raised same-property NOI guidance but lowered EBITDAre and FFO guidance due to management fees. The company has $260.7M in liquidity and a debt-to-EBITDAre ratio of 8.2x.

investing.com
$ENSGHighAI 8/10

ENSG Q3 deep dive: organic growth and acquisitions drive occupancy and margin gains

Ensign Group (ENSG) reported Q3 revenue of $1.48 billion, missing estimates by 7.1%, but beat adjusted EBITDA expectations. The company raised full-year revenue guidance to $5.91 billion and GAAP EPS guidance to $7.98. Occupancy and skilled mix gains, along with acquisitions, drove growth. Management highlighted clinical model success and market expansion, including entry into Florida.

finance.yahoo.com
$ENSGMed

Truist raises Ensign Group stock price target to $210 on margins

Truist Securities raised its price target on The Ensign Group (NASDAQ:ENSG) to $210 from $207, citing strong Q3 results with revenue of $5.67B and EBITDA of $621.52M. The company beat EPS estimates and raised fiscal 2026 guidance. Truist noted positive occupancy trends, labor commentary, and M&A activity. ENSG's Q3 revenue missed estimates but earnings exceeded expectations.

investing.com
$ENSGHighAI 8/10

The Ensign Group Q3 Earnings Call Highlights

Ensign Group (ENSG) reported Q3 earnings, raising its full-year 2026 adjusted earnings guidance to $7.94-$8.02 per share and revenue outlook to $5.89-$5.92 billion. The company added 22 operations, including nine in Florida, and discussed turnaround efforts for acquired facilities. Ensign had $337.6 million in cash and $512.3 million in cash flow from operations as of Sept. 30, with $1 billion in available capital.

finance.yahoo.com
$ENSGHighAI 8/10

Ensign Group Inc (ENSG) Q3 2026 Earnings Call Highlights: Raised Guidance, Strong

Ensign Group Inc (ENSG) raised its 2026 guidance, citing strong occupancy and skilled mix growth. Challenges include integrating 22 new operations, particularly in Florida and Texas, which may take over a year to contribute positively. The company faces risks from reimbursement variations and litigation environments. CEO Barry Port noted strong clinical outcomes and managed care partnerships. CFO Suzanne Snapper highlighted $1B in available funds for growth.

finance.yahoo.com
$ENSGMedAI 8/10

Nursing Home Giant Ensign Touts $1B for Future Investments, Census Momentum and New CMS Survey Performance in 3Q

Ensign Group (ENSG) reported Q3 earnings of $2.03 per share, up 23.8% YoY, and revenue of $1.48B, up 14.5%. CEO Barry Port highlighted strong occupancy, skilled-mix growth, and improved CMS survey performance. The company raised full-year 2026 guidance and announced 22 new acquisitions. Ensign has $1B in cash and credit capacity for future investments.

skillednursingnews.com